NCT02194686View on ClinicalTrials.gov

Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

August 31, 2014

Conditions
Cardiovascular Diseases
Interventions
DRUG

Cilostazol

One tablet (100 mg) twice per day for 12 weeks

DRUG

Dummy Placebo

One tablet twice per day for 12 weeks

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
collaborator

Department of Health, Executive Yuan, R.O.C. (Taiwan)

OTHER_GOV

lead

National Cheng-Kung University Hospital

OTHER

NCT02194686 - Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease | Biotech Hunter | Biotech Hunter